Merative software empowers researchers at CHU Sainte-Justine to safely study medication associations with pregnancy outcomes by providing access to comprehensive longitudinal, real-world data. Since pregnant women are often excluded from clinical trials, this sophisticated software bridges the information gap by offering a lifetime of insights from diverse patient histories. The technology allows for a detailed analysis of risks and benefits before, during, and after pregnancy, ensuring evidence-based care for expecting families. By leveraging these robust digital tools, the institution can identify critical health trends and improve safety protocols. Ultimately, Merative provides the essential analytical framework to transform raw data into actionable knowledge, enhancing maternal and neo

Join for free to read